C
Caribou Biosciences, Inc. (CRBU)
NMS – Real Time Price. Currency in USD
1.68
+0.11 (7.01%)
At close: Jun 26, 2026, 4:00 PM EDT
1.66
-0.02 (-1.19%)
After-hours: Jun 26, 2026, 7:06 PM EDT
Get all premium features to the best stock analysis tool
Find any stock by ticker or company name
NMS – Real Time Price. Currency in USD
1.68
+0.11 (7.01%)
At close: Jun 26, 2026, 4:00 PM EDT
1.66
-0.02 (-1.19%)
After-hours: Jun 26, 2026, 7:06 PM EDT
No Data
There are no news for this stock.
Total debt $26.9M significantly exceeds cash reserves ($12.1M), raising financial stability concerns
Total current assets $122.4M exceed Total current liabilities $19.7M, highlighting excellent liquidity
Debt-to-equity ratio (0.3) is well below the industry average (0.3), showcasing prudent financial management
Interest expense exists but EBIT data is unavailable, indicating potential profitability concerns
Negative free cash flow -$27.1M limits the company's ability to reinvest or pay down debt
| NAME | RATIO | INDUSTRY | 5Y TREND | SCORE |
|---|---|---|---|---|
| Current ratio | 6.22 | 6.05 | 10 | |
| Quick ratio | 6.22 | 5.63 | 10 | |
| Debt to Equity | 0.26 | 0.30 | 8.0 | |
| Debt to Assets | 0.18 | 1.04 | 8.0 | |
| Interest coverage | N/A | -16.91 | 1.0 | |
| Weighted average score | 7.4 | |||
| METRIC | 2022 | 2023 | 2024 | 2025 | TTM |
|---|---|---|---|---|---|
| Total Revenue | 14M | 34M | 10M | 11M | 11M |
| Gross Profit | 10M | 31M | 6M | 8M | 8M |
| Operating Income | -106M | -116M | -167M | -136M | -120M |
| Net Income | -99M | -102M | -149M | -148M | -133M |
| EBITDA | -103M | -113M | -163M | -133M | -116M |
| NAME | REVENUE GROWTH | EPS GROWTH | SCORE |
|---|---|---|---|
| Current quarter | -14.55 | 7.43 | 3.0 |
| Next quarter | -0.05 | -21.33 | 1.0 |
| Current year | 129.84 | 24.91 | 10 |
| Next year | 17.51 | -18.93 | 5.0 |
| Weighted average score | 4.8 | ||
| NAME | REVENUE | NET INCOME | EPS | FCF | SCORE |
|---|---|---|---|---|---|
| Q/Q | -39.17 | 5.3 | 7.14 | -31.28 | 3.0 |
| Y/Y | 1.87 | 37.27 | 39.53 | 28.36 | 8.3 |
| 3y average | 29.86 | -16.01 | -0.01 | -7.51 | 3.3 |
| 5y average | 22.31 | -38.32 | 5.55 | -41.41 | 4.3 |
| Weighted average score | 4.7 | ||||
Insufficient positive free cash flow for DCF analysis
| NAME | CURRENT | INDUSTRY | SCORE |
|---|---|---|---|
| Dividend yield | 0.00 | N/A | 1.0 |
| Payout ratio | 0.00 | N/A | 1.0 |
| 5-year dividend growth rate | N/A | N/A | 1.0 |
| Years of dividend increase | N/A | N/A | 1.0 |
| Weighted average score | 1.0 | ||
Insufficient positive free cash flow for DCF analysis
| NAME | SCALE | SCORE |
|---|---|---|
| Market share | None | 1.0 |
| Intangible assets | None | 1.0 |
| Switching costs | None | 1.0 |
| Network effect | None | 1.0 |
| Economies of scale | None | 1.0 |
| Weighted average score | 1.0 | |